UK Parliamentary Debate on E-cigarette Regulation and WHO Position

Jan.19.2024
UK Parliamentary Debate on E-cigarette Regulation and WHO Position
UK Parliament held a backbench debate on e-cigarette regulation, challenging the WHO's negative stance, ahead of COP10.

On January 18th, a backbench debate took place in the British Parliament, allowing backbench MPs to raise local or national issues and receive responses from relevant government ministers. The debate focused on the regulation of e-cigarettes in the UK, the World Health Organization (WHO), and the differing approaches between the organization and the British government towards e-cigarettes. The debate was initiated by MPs Andrew Lewer, Mr Virendra Sharma, and Martyn Day, in an attempt to challenge the WHO's negative position on the regulation of e-cigarettes.

UK Parliamentary Debate on E-cigarette Regulation and WHO Position
Member of Parliament Andrew Lewer speaks in the backbench debate after 18th January. |Image source: 2FIRSTS.


Do not view this issue naively.

UK Parliamentary Debate on E-cigarette Regulation and WHO Position
Virendra Sharma spoke at the back seat debate on January 18. Image source: 2FIRSTS.


The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) tenth Conference of the Parties, which was previously forced to be postponed, has now been officially scheduled to take place from February 5 to 10 in Panama. The United Kingdom will be sending a delegation to participate in this conference, and discussions on emerging tobacco issues will be one of the key focal points.

UK Parliamentary Debate on E-cigarette Regulation and WHO Position
Dame Andrea Jacqueline Leadsom spoke in the debate on January 18|Image source: 2FIRSTS


For years, the World Health Organization (WHO) has been dedicated to controlling the use of tobacco and nicotine products, particularly e-cigarettes. According to a report dated December 14, 2023, WHO emphasizes the need for immediate action to regulate e-cigarettes in order to protect children and non-smokers, while minimizing the health hazards for the general population. WHO points out that the nicotine found in e-cigarettes is highly addictive and harmful to health.


MP Andrew defended this during the meeting. He cited a survey conducted by Cancer Research UK, stating that "it is not nicotine, but rather the chemicals produced during the combustion of tobacco that cause lung cancer.


Based on these theoretical findings, Andrew, a senator, views vape as a "tobacco harm reduction product" throughout the entire debate, which aligns with the overall direction of the UK government's anti-smoking policy. He firmly maintains two central arguments. First, new tobacco products, including vape, should not be subjected to the same tax rates as traditional cigarettes. Second, flavored vape should not be prohibited. "If there is no tax advantage (in terms of pricing) and no flavor difference (compared to cigarettes), what else would motivate people to quit smoking?" he argues.


Andrew not only called on the British delegation to uphold the country's stance on the efficacy of e-cigarettes in smoking cessation at the international conference, but also questioned the entire WHO institution during the debate. He also raised the need to review the amount of donations from the UK to the organization. This is because the UK is currently one of the largest financial contributors to the WHO and it is important to ensure that "taxpayer's money is being used wisely.


The co-founder of the debate, Vilendra, who spoke later, stated, "COP10 and WHO should not make it harder for people who want to quit smoking by relying on e-cigarettes." Therefore, the policies that overly regulate e-cigarettes, heated tobacco, and oral nicotine pouches are subject to debate.


He also mentioned that while the United Kingdom is a global leader in tobacco harm reduction policies, there is still room for improvement by drawing on the advanced experiences of other countries in effectively controlling smoking using alternative nicotine products. He cited examples from Japan and Sweden, where heated tobacco and oral tobacco products have significantly reduced smoking rates. The UK can still find better ways to strike a balance and achieve a more desirable outcome.


Karin Marguerite Smyth, the Labour Party politician and member of the Bristol North constituency, also participated in the debate. After expressing her anticipation for the UK delegation's participation in the treaty conference and conveying the nation's voice, she stated that many MPs had received letters of inquiry from their constituents regarding e-cigarettes and smoking, as this would be a central topic at COP10. Voters are concerned that this conference will impact the future use of e-cigarettes as a smoking cessation tool for UK citizens. She inquired whether the Minister of Public Health plans to include other nicotine products in the regulatory process in an upcoming government bill.


Dame Andrea Jacqueline Leadsom, who took office as Deputy Minister of Public Health, Life Origin and Primary Healthcare Affairs since November 2023, is responsible for responding to inquiries in this debate. She holds contrary opinions to some of the arguments raised by the aforementioned members of parliament.


Using her own experience as a teenager who smoked and struggled to quit, she refutes the idea that nicotine is completely harmless and reiterates its addictive nature. She also questions some of the views held by the aforementioned lawmakers. She argues that flavors like cherry soda and bubblegum are not intended for adults, evident in their child-friendly packaging and association with candy-like products. E-cigarettes, displayed alongside candies at low prices affordable for pocket money, raise concerns. Therefore, she urges the lawmakers not to naively approach this issue and emphasizes that robust enforcement measures are necessary to prevent the sale of e-cigarettes to minors.


In anticipation of the upcoming COP10, she described the UK as a "distinctive" country when it comes to the issue of e-cigarettes. Therefore, she intends to clearly outline the UK's stance at the conference, stating that e-cigarettes are a crucial tool in helping adults quit smoking. "However, in terms of altering the current level of donations to the WHO, the UK government leans towards maintaining the existing amount." She concluded by stating her intention to provide a statement to Parliament after COP10, to provide an account of the conference proceedings.


The E-cigarette in the Backseat Debate


This is not the first time that tobacco (or novel tobacco) has emerged as a hot issue in the British political debate.


According to incomplete statistics, in June 2020, members of the coalition government initiated a debate against the ban on importing liquid nicotine for e-cigarettes. On November 3, 2022, the lower house also debated the "Independent Review of the 2030 Smoking Ban Policy." Just earlier this week, there was another debate on e-cigarettes. On January 16, Conservative Party member Peter Gibson chaired a discussion on the issues of black-market/gray-market vape products (illegally imported) and underage illegal use of e-cigarettes.


There has been a significant difference in stance between the United Kingdom and the World Health Organization (WHO) regarding new tobacco products, particularly vaping. The British government has consistently supported e-cigarettes as a substitute to reduce the harm caused by smoking. According to the UK government's viewpoint, e-cigarettes can help smokers quit and pose much lower risks compared to traditional tobacco products.


A report by Policy Exchange, a British policy think tank, has revealed the significant impact of smoking on the economy. It suggests that reducing smoking rates not only improves health conditions and alleviates the burden on the national healthcare system, but also enhances productivity and boosts economic growth.


2FIRSTS will continue to monitor the upcoming Tenth Conference of the Parties to the WHO Framework Convention on Tobacco Control (COP10) to be held in Panama, as well as the tobacco control policy in the United Kingdom, and developments in both traditional and new forms of tobacco regulation.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
China’s vape-related exports reached $1.047 billion in July 2026, up 16.5% year on year and the highest monthly total of the year. Growth was heavily concentrated in the U.S., where exports jumped 53.5% to $404 million and accounted for 94.9% of the overall increase. Exports to all other markets rose just 1.2%. By category, nicotine-containing non-combustible products—primarily vapes—under HS24041200 rose 24.7% and generated 95.5% of the total increase. Vape-device exports under HS85434000 fell 0.4%, while other nicotine-substitute products under HS24041990 grew 88.9% but remained comparatively small.
DATA
Aug.24
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14